Research Roundup

Debbie Rigby takes a look at the latest in research news Safety of Proton Pump Inhibitors in patients receiving rivaroxaban or aspirin In a large placebo-controlled randomized trial, pantoprazole was not associated with any adverse event when used for 3 years, with the possible exception of an increased risk of enteric infections. C difficile infection

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Polypharmacy on the rise
Next ‘Community pharmacists may never actually meet the resident.’